Subscribe

|Articles|March 21, 2023

PAP 2023: Gwen Cooper Discusses Her Past Experiences and Becoming Accessia Health CEO

Gwen Cooper explains how her past experiences led to her being named Accessia Health CEO.

In an interview with Pharma Commerce Editor, Nicholas Saraceno, Gwen Cooper, president & CEO of Accessia Health, comments on her past experiences preparing her for becoming CEO of Accessia Health.

Newsletter

Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

Related Content

Philip Sclafani: Will PBM Reform Actually Lower Net Drug Costs?

ByPhilip Sclafani,Stephen Appezzato

June 19th 2026

How GLP-1 Growth and Specialty Drugs Are Driving Cost Pressure

ByPhilip Sclafani,Stephen Appezzato

June 18th 2026

Miranda Delatore, CoverMyMeds, on how a connected specialty access and affordability ecosystem is eliminating delays, reducing friction, and transforming the way biopharma manufacturers get patients started on life-changing therapies faster than ever before.

What Does Specialty Access Look Like When Built to Scale

ByMiranda Delatore, DNP, RN, NEA‑BC, CoverMyMeds

June 9th 2026

Sponsored

Danny Williams

Danny Williams on What the Next Five Years Hold for Pharma 3PLs

ByDanny Williams,Stephen Appezzato

June 9th 2026

Danny Williams

How AI and CGTs Are Reshaping Pharma 3PL

ByDanny Williams,Stephen Appezzato

June 8th 2026

Trending on Pharmaceutical Commerce

Why the Direct Access Channel Is No Longer Optional for Pharma

Why UPS Committed $48M to Cold-Chain Cross-Dock Buildout

The RWE Problem Isn't Quality. It's Communication.

How the US Section 301 Probe Targets Germany's Drug Pricing

Payers Want Real-World Evidence. Why Aren't They Using It?